Condition: ST-Segment Elevation Myocardial Infarction (STEMI) · No-Reflow Phenomenon · Coronary Slow Flow · Sponsor: National Institute of Cardiovascular Diseases, Pakistan
Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.
This description comes directly from the study's public registry record.
Muhammad Nauman Khan, FCPS · +923453549634 · nkhan116@yahoo.com
Khalid Naseeb, FCPS · +923002469284 · khalidnaseeb50@gmail.com
Always discuss trial participation with your own doctor first.
| National Institute of Cardiovascular Diseases | Karachi, Sindh, Pakistan | Recruiting |
| National Institute of Cardiovascular Diseases | Karachi, Sindh, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07536802